{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:31Z","timestamp":1787024551586,"version":"build-2736575974"},"reference-count":51,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.2169\/internalmedicine.5995-25","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T22:07:22Z","timestamp":1756332442000},"page":"951-958","source":"Crossref","is-referenced-by-count":1,"title":["Clinico-epidemiological Characteristics of &lt;i&gt;Helicobacter pylori&lt;\/i&gt;-na\u00efve Undifferentiated Gastric Cancer"],"prefix":"10.2169","volume":"65","author":[{"given":"Yuichiro","family":"Kemmoto","sequence":"first","affiliation":[{"name":"Cancer Institute Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare Ichikawa Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hirasawa","sequence":"additional","affiliation":[{"name":"Cancer Institute Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Shinjuku Tsurukame Clinic, Digestive Disease Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Koganei Tsurukame Clinic, Endoscopy Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Mochida","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare Ichikawa Hospital, Department of Gastroenterology, Japan"},{"name":"Koganei Tsurukame Clinic, Endoscopy Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yanai","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizu","family":"Yokoi","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hayashi","sequence":"additional","affiliation":[{"name":"National Center for Global Health and Medicine, Department of Medical Examination Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichiro","family":"Ozawa","sequence":"additional","affiliation":[{"name":"Japan Community Health Care Organization Yamanashi Hospital, Department of Gastroenterology and Hepatology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Uraushihara","sequence":"additional","affiliation":[{"name":"Showa General Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Minato","sequence":"additional","affiliation":[{"name":"NTT Medical Center Tokyo, Department of Gastrointestinal Endoscopy, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Musashino Red Cross Hospital, Department of Gastroenterology and Hepatology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Ueyama","sequence":"additional","affiliation":[{"name":"Juntendo University School of Medicine, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikinori","family":"Kataoka","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare Mita Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Toyama","sequence":"additional","affiliation":[{"name":"New Tokyo Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Mizokami","sequence":"additional","affiliation":[{"name":"New Tokyo Hospital, Department of Medical Examination Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Suzuki","sequence":"additional","affiliation":[{"name":"International University of Health and Welfare Ichikawa Hospital, Department of Gastroenterology, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Uemura N, Okamoto S, Yamamoto S, et al. <i>Helicobacter pylori<\/i> infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.","DOI":"10.1056\/NEJMoa001999"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ishibashi F, Suzuki S, Nagai M, Mochida K, Morishita T. Optimizing <i>Helicobacter pylori<\/i> treatment: an updated review of empirical and susceptibility test-based treatments. Gut Liver 17: 684-697, 2023.","DOI":"10.5009\/gnl220429"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Tsuda M, Asaka M, Kato M, et al. Effect on <i>Helicobacter pylori<\/i> eradication therapy against gastric cancer in Japan. Helicobacter 22: e12415, 2017.","DOI":"10.1111\/hel.12415"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ueyama H, Yao T, Nakashima Y, et al. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol 34: 609-619, 2010.","DOI":"10.1097\/PAS.0b013e3181d94d53"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kobayashi M, Takeuchi M, Ajioka Y, et al. Mucin phenotype and narrow-band imaging with magnifying endoscopy for differentiated-type mucosal gastric cancer. J Gastroenterol 46: 1064-1070, 2011.","DOI":"10.1007\/s00535-011-0418-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen YC, Malfertheiner P, Yu HT, et al. Global prevalence of <i>Helicobacter pylori<\/i> infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology 166: 605-619, 2024.","DOI":"10.1053\/j.gastro.2023.12.022"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Yamada A, Kaise M, Inoshita N, et al. Characterization of <i>Helicobacter pylori<\/i>-na\u00efve early gastric cancers. Digestion 98: 127-134, 2018.","DOI":"10.1159\/000487795"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kotani S, Shibagaki K, Hirahara N, et al. Clinicopathologic differences of gastric neoplasms between <i>Helicobacter pylori<\/i>-infected and -na\u00efve patients: a multicenter retrospective analysis. J Gastroenterol 59: 1-10, 2024.","DOI":"10.1007\/s00535-023-02050-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ishibashi F, Hirasawa T, Ueyama H, Minato Y, Suzuki S. Exploring quality indicators for the detection of <i>Helicobacter pylori<\/i>-na\u00efve gastric cancer: a cross-sectional nationwide survey. Clin Endosc 56: 460-469, 2023.","DOI":"10.5946\/ce.2022.167"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ishibashi F, Kobayashi K, Kawakami T, et al. Quality management system for screening esophagogastroduodenoscopy improves detection of <i>Helicobacter pylori<\/i>-negative interval gastric cancer. Endosc Int Open 9: E1900-E1908, 2021.","DOI":"10.1055\/a-1594-1833"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishibashi F, Kobayashi K, Fukushima K, et al. Quality indicators for the detection of <i>Helicobacter pylori<\/i>-negative early gastric cancer: a retrospective observational study. Clin Endosc 53: 698-704, 2020.","DOI":"10.5946\/ce.2019.203"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kato S, Matsukura N, Tsukada K, et al. <i>Helicobacter pylori<\/i> infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci 98: 790-794, 2007.","DOI":"10.1111\/j.1349-7006.2007.00478.x"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Matsuo T, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K. Low prevalence of <i>Helicobacter pylori<\/i>-negative gastric cancer among Japanese. Helicobacter 16: 415-419, 2011.","DOI":"10.1111\/j.1523-5378.2011.00889.x"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Sugano S, Kato M, Suzuki M, et al. Frequency of <i>Helicobacter pylori<\/i>-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion 86: 59-65, 2012.","DOI":"10.1159\/000339176"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal <i>Helicobacter pylori<\/i>-negative undifferentiated-type early gastric cancer: comparison with <i>Helicobacter pylori<\/i>-positive early gastric cancer. Gastric Cancer 19: 160-165, 2016.","DOI":"10.1007\/s10120-014-0452-1"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Horiuchi Y, Fujisaki J, Ishizuka N, et al. Study on clinical factors involved in <i>Helicobacter pylori<\/i>-uninfected, undifferentiated-type early gastric cancer. Digestion 96: 213-219, 2017.","DOI":"10.1159\/000481817"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbio1 Immunol Scand 64: 31-49, 1965.","DOI":"10.1111\/apm.1965.64.1.31"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mabe K, Inoue K, Kamada T, Kato K, Kato M, Haruma K. Endoscopic screening for gastric cancer in Japan: current status and future perspectives. Dig Endosc 34: 412-419, 2022.","DOI":"10.1111\/den.14063"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Ishibashi F, Okusa K, Tokai Y, et al. A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of <i>H. pylori<\/i>-na\u00efve gastric neoplasms. Gastric Cancer 27: 1078-1087, 2024.","DOI":"10.1007\/s10120-024-01525-2"},{"key":"20","unstructured":"20. Kyoto Classification of Gastritis. 1st ed. Haruma K, Kato M, Inoue K, Murakami K, Kamada T, Eds. Nihon Medical Center, Tokyo, 2017."},{"key":"21","unstructured":"21. WHO Classification of Tumours: Digestive System Tumours. 5th ed. WHO Classification of Tumours Editorial Board, Ed. IARC, Lyon, 2019."},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112, 2011.","DOI":"10.1007\/s10120-011-0041-5"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Hamashima C, Ogoshi K, Okamoto M, Shabana M, Kishimoto T, Fukao A. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS ONE 8: e79088, 2013.","DOI":"10.1371\/journal.pone.0079088"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hamashima C, Shabana M, Okada K, Okamoto M, Osaki Y. Mortality reduction from gastric cancer by endoscopic and radiographic screening. Cancer Sci 106: 1744-1749, 2015.","DOI":"10.1111\/cas.12829"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Jun JK, Choi KS, Lee HY, et al. Effectiveness of the Korean national cancer screening program in reducing gastric cancer mortality. Gastroenterology 152: 1319-1328.e7, 2017.","DOI":"10.1053\/j.gastro.2017.01.029"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Noh CK, Lee E, Lee GH, et al. Association of intensive endoscopic screening burden with gastric cancer detection. JAMA Netw Open 4: e2032542, 2021.","DOI":"10.1001\/jamanetworkopen.2020.32542"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kusano C, Gotoda T, Ishikawa H, Suzuki S, Ikehara H, Matsuyama Y. Gastric cancer detection rates using gastrointestinal endoscopy with serological risk stratification: a randomized controlled trial. Gastrointest Endosc 100: 55-63.e1, 2024.","DOI":"10.1016\/j.gie.2024.01.022"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Gotoda T, Ishikawa H, Kusano C, et al. Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study). Gastric Cancer 27: 36-48, 2024.","DOI":"10.1007\/s10120-023-01449-3"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining <i>Helicobacter pylori<\/i> antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54: 764-768, 2005.","DOI":"10.1136\/gut.2004.055400"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Okimoto E, Adachi K, Ebisutani Y, Ishimura N, Ishihara S. Prevalence of gastric epithelial tumors in <i>Helicobacter pylori<\/i>-uninfected individuals undergoing a medical checkup. Intern Med 63: 2251-2258, 2024.","DOI":"10.2169\/internalmedicine.2955-23"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yoshimura D, Yoshimura R, Kato S, et al. Tu1331-Gastric cancer without <i>Helicobacter pylori<\/i> infection other than gastric cardia cancer is less invasive. Gastroenterology 154: S936, 2018.","DOI":"10.1016\/S0016-5085(18)33157-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Naka T, Hashimoto T, Cho H, et al. Sporadic and familial adenomatous polyposis-associated foveolar-type adenoma of the stomach. Am J Surg Pathol 47: 91-101, 2023.","DOI":"10.1097\/PAS.0000000000001949"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Naka T, Hashimoto T, Yoshida T, Yatabe Y, Sekine S. <i>KLF4<\/i> c.A1322C mutation is a consistent and specific genetic feature of raspberry-like foveolar-type adenoma of the stomach. Am J Surg Pathol 47: 521-523, 2023.","DOI":"10.1097\/PAS.0000000000002012"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Zhai Z, Hu W, Huang Z, Chen Z, Lu S, Gong W. Gastric adenocarcinoma of the fundic gland type: a review of the literature. JGH Open 7: 812-825, 2023.","DOI":"10.1002\/jgh3.13014"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Tanaka C, Otani K, Tamoto M, et al. Efficacy evaluation of upper gastrointestinal endoscopy screening for secondary prevention of gastric cancer using the standardized detection ratio during a medical check-up in Japan. J Clin Biochem Nutr 74: 253-260, 2024.","DOI":"10.3164\/jcbn.24-28"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Takahashi Y, Yamamichi N, Kubota D, et al. Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study. Gastric Cancer 25: 481-489, 2022.","DOI":"10.1007\/s10120-021-01273-7"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Takeuchi C, Yamamichi N, Shimamoto T, Takahashi Y, Mitsushima T, Koike K. Gastric polyps diagnosed by double-contrast upper gastrointestinal barium X-ray radiography mostly arise from the <i>Helicobacter pylori<\/i>-negative stomach with low risk of gastric cancer in Japan. Gastric Cancer 20: 314-321, 2017.","DOI":"10.1007\/s10120-016-0607-3"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Yamamichi N, Hirano C, Ichinose M, et al. Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. Gastric Cancer 19: 1016-1022, 2016.","DOI":"10.1007\/s10120-015-0558-0"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hirai R, Hirai M, Otsuka M, et al. Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-<i>Helicobacter pylori<\/i> antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program. J Gastroenterol 58: 848-855, 2023.","DOI":"10.1007\/s00535-023-02010-w"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Oda T, Kanai Y, Oyama T, et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A 91: 1858-1862, 1994.","DOI":"10.1073\/pnas.91.5.1858"},{"key":"41","unstructured":"41. Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58: 4086-4089, 1998."},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 392: 402-405, 1998.","DOI":"10.1038\/32918"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Pharoah PD, Guilford P, Caldas C; The International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121: 1348-1353, 2001.","DOI":"10.1053\/gast.2001.29611"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Nikaido M, Kakiuchi N, Miyamoto S, et al. Indolent feature of <i>Helicobacter pylori<\/i>-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations. Gastric Cancer 24: 1102-1114, 2021.","DOI":"10.1007\/s10120-021-01191-8"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Rota M, Possenti I, Valsassina V, et al. Dose-response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis. Gastric Cancer 27: 197-209, 2024.","DOI":"10.1007\/s10120-023-01459-1"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Tanaka H, Mackenbach PJ, Kobayashi Y. Widening socioeconomic inequalities in smoking in Japan, 2001-2016. J Epidemiol 31: 369-377, 2021.","DOI":"10.2188\/jea.JE20200025"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Zhang Z, Gao N, Liu K, et al. Risk factors of missed early gastric cancer in endoscopic resected population: a retrospective, case-control study. Surg Endosc 38: 4380-4389, 2024.","DOI":"10.1007\/s00464-024-10970-0"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Muraishi J, Miyaoka M, Imamura K, et al. A case of gastric signet-ring cell carcinoma with a long-term retrospective follow-up of 17 years. Clin J Gastroenterol 14: 1337-1343, 2021.","DOI":"10.1007\/s12328-021-01443-1"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Nikaido M, Miyamoto S, Minato Y, Muto M. Intramucosal signet-ring cell carcinoma with reduced expression of E-cadherin in a <i>Helicobacter pylori<\/i>-uninfected stomach remained unchanged for 8 years. Clin J Gastroenterol 15: 268-269, 2022.","DOI":"10.1007\/s12328-021-01545-w"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Namikawa K, Tanaka N, Ota Y, et al. Genomic features of <i>Helicobacter pylori<\/i>-na\u00efve diffuse-type gastric cancer. J Pathol 258: 300-311, 2022.","DOI":"10.1002\/path.6000"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Ishibashi F, Suzuki S, Kobayashi K, et al. Cost-effective endoscopic screening for gastric cancer in a cohort with low <i>Helicobacter pylori<\/i> prevalence. J Gastroenterol Hepatol 39: 2424-2431, 2024.","DOI":"10.1111\/jgh.16715"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/7\/65_5995-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:55:30Z","timestamp":1775274930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/7\/65_5995-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5995-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"5995-25"}}